Molecular Medicine Today

In utero gene therapy: one step closer to reality
pp. 505-505(1)
Author: Senior K.

A noninvasive prognostic indicator for bladder cancer
pp. 506-507(2)
Author: Fricker J.

Selecting antibodies that block the HIV-1 coreceptor
pp. 507-507(1)
Author: Dorrell S.

Restoring interleukin 2 production in AIDS patients
pp. 508-508(1)
Author: Dorrell S.

Leukocyte depletion for leukaemia and multiple sclerosis
pp. 508-508(1)
Author: Bonn D.

A new gene Web site for all
pp. 509-509(1)
Author: Sansom C.

An SH2 domain stands between infectious mononucleosis and a fatal lymphoproliferative disease
pp. 510-510(1)
Author: Evans K.L.

Aspirin as a cancer-preventing drug
pp. 510-510(1)
Author: Ivanov E.

Crosstalk among cancer signalling pathways
pp. 511-511(1)
Author: Bustin S.A.

Making an impression on X-linked mental retardation
pp. 511-511(1)
Author: Osborne L.R.

Pathogenesis and immunointervention strategies for psoriasis
pp. 512-513(2)
Author: Nickoloff B.J.

New molecular targets for anticancer therapy
pp. 514-516(3)
Authors: Normanno N.; Agrawal S.

Protein dysfunction: cause and effect in human disease
pp. 517-517(1)
Author: Hingorani A.D.

A piece in the puzzle: an ion channel candidate gene for schizophrenia
pp. 518-524(7)
Authors: Gargus J.J.; Fantino E.; Gutman G.A.

Niemann-Pick C disease: cholesterol handling gone awry
pp. 525-531(7)
Authors: Morris J.A.; Carstea E.D.

Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET
pp. 532-539(8)
Authors: Andrews T.C.; Brooks D.J.

The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy
pp. 540-549(10)
Authors: Lopez-Larrea C.; Gonzalez S.; Martnez-Borra J.